Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 262

1.

Validation of an Algorithm for Predicting Hypoglycemia From Continuous Glucose Measurements and Heart Rate Variability Data.

Cichosz SL, Henriksen MM, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U, Fleischer J.

J Diabetes Sci Technol. 2019 Jul 31:1932296819864625. doi: 10.1177/1932296819864625. [Epub ahead of print] No abstract available.

PMID:
31364406
2.

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.

Agesen RM, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen T, Juhl CB, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U.

BMC Endocr Disord. 2019 Jul 23;19(1):78. doi: 10.1186/s12902-019-0408-x.

3.

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, Jorsal A, Theilade S, Parving HH, Hansen TW, Hazen SL, Pedersen O, Rossing P.

Diabetes Care. 2019 Aug;42(8):1512-1520. doi: 10.2337/dc19-0048. Epub 2019 May 23.

PMID:
31123156
4.

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes.

Hansen CS, Frandsen CS, Fleischer J, Vistisen D, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU, Dejgaard TF.

Front Endocrinol (Lausanne). 2019 Apr 12;10:242. doi: 10.3389/fendo.2019.00242. eCollection 2019.

5.

Prediction of In-Hospital Pressure Ulcer Development.

Cichosz SL, Voelsang AB, Tarnow L, Hasenkam JM, Fleischer J.

Adv Wound Care (New Rochelle). 2019 Jan 1;8(1):1-6. doi: 10.1089/wound.2018.0803. Epub 2019 Jan 5.

6.

Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudication.

Afzelius P, Molsted S, Tarnow L.

Scand J Clin Lab Invest. 2018 Oct;78(6):456-463. doi: 10.1080/00365513.2018.1497803. Epub 2018 Sep 27.

PMID:
30261748
7.

LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.

Game F, Jeffcoate W, Tarnow L, Jacobsen JL, Whitham DJ, Harrison EF, Ellender SJ, Fitzsimmons D, Löndahl M; LeucoPatch II trial team.

Lancet Diabetes Endocrinol. 2018 Nov;6(11):870-878. doi: 10.1016/S2213-8587(18)30240-7. Epub 2018 Sep 19.

PMID:
30243803
8.

Carotid intima media thickness and ankle brachial index are inversely associated in subjects with and without diabetes.

Winckler K, Wiinberg N, Jensen AK, Thorsteinsson B, Lundby-Christensen L, Heitmann BL, Jensen GB, Tarnow L.

Scand J Clin Lab Invest. 2018 Oct;78(6):464-469. doi: 10.1080/00365513.2018.1499124. Epub 2018 Aug 3.

PMID:
30073874
9.

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial.

Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS, Stellfeld M, Tornøe K, Pratley RE; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Care. 2018 Oct;41(10):2229-2235. doi: 10.2337/dc18-1094. Epub 2018 Aug 2.

PMID:
30072400
10.

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Nordklint AK, Almdal TP, Vestergaard P, Lundby-Christensen L, Boesgaard TW, Breum L, Gade-Rasmussen B, Sneppen SB, Gluud C, Hemmingsen B, Jensen T, Krarup T, Madsbad S, Mathiesen ER, Perrild H, Tarnow L, Thorsteinsson B, Vestergaard H, Lund SS, Eiken P.

Osteoporos Int. 2018 Nov;29(11):2517-2526. doi: 10.1007/s00198-018-4637-z. Epub 2018 Jul 19.

PMID:
30027438
11.

Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea.

Hvelplund Kristiansen M, Banghøj AM, Laugesen E, Tarnow L.

Diabet Med. 2018 Oct;35(10):1391-1398. doi: 10.1111/dme.13666. Epub 2018 May 24.

PMID:
29763980
12.

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.

Agesen RM, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Jensen T, Parving HH, Thorsteinsson B, Tarnow L, Pedersen-Bjergaard U.

Diabetes Technol Ther. 2018 Mar;20(3):247-256. doi: 10.1089/dia.2017.0372. Epub 2018 Mar 12.

PMID:
29565719
13.

Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea.

Rehling T, Banghøj AM, Kristiansen MH, Tarnow L, Molsted S.

J Diabetes Res. 2017;2017:4121794. doi: 10.1155/2017/4121794. Epub 2017 Sep 25.

14.

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Jorsal A, Parving HH, Tarnow L, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9.

15.

The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.

Game F, Jeffcoate W, Tarnow L, Day F, Fitzsimmons D, Jacobsen J.

Trials. 2017 Oct 10;18(1):469. doi: 10.1186/s13063-017-2216-9.

16.

Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.

Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Sørensen J, Harms HJ, Flyvbjerg A, Tarnow L, Kistorp C, Gustafsson I, Bøtker HE, Wiggers H.

J Nucl Cardiol. 2019 Apr;26(2):585-597. doi: 10.1007/s12350-017-1000-2. Epub 2017 Aug 2.

PMID:
28770459
17.

Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.

Fleischer J, Laugesen E, Cichosz SL, Hoeyem P, Dejgaard TF, Poulsen PL, Tarnow L, Hansen TK.

J Diabetes Complications. 2017 Sep;31(9):1389-1393. doi: 10.1016/j.jdiacomp.2017.06.013. Epub 2017 Jun 30.

PMID:
28728915
18.

Readmission to hospital of medical patients - A cohort study.

Rasmussen MG, Ravn P, Molsted S, Tarnow L, Rosthøj S.

Eur J Intern Med. 2017 Dec;46:19-24. doi: 10.1016/j.ejim.2017.07.008. Epub 2017 Jul 16.

PMID:
28724505
19.

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.

Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P.

Kidney Int. 2017 Nov;92(5):1242-1248. doi: 10.1016/j.kint.2017.04.018. Epub 2017 Jul 14.

PMID:
28712855
20.

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study.

Hanssen NMJ, Scheijen JLJM, Jorsal A, Parving HH, Tarnow L, Rossing P, Stehouwer CDA, Schalkwijk CG.

Diabetes. 2017 Aug;66(8):2278-2283. doi: 10.2337/db16-1578. Epub 2017 Jun 6.

Supplemental Content

Loading ...
Support Center